NCT05264805

Effectiveness of Port Site Bupivacaine Injection in Postoperative Pain Reduction After Lap. Chole

A Randomized Controlled Trial of Port Site Subcutaneous Injection of Bupivacaine to Determine the Effectiveness of Postoperative Pain Relief After Laparoscopic Cholecystectomy

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 166 (estimated)
• Sponsor: Hamdard University · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.

Detailed description

The study is being done to determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.

Conditions

• Pain, Postoperative

Interventions

Type	Name	Description
DRUG	0.25% Bupivacaine	20ml of 0.25% Bupivacaine subcutaneous infiltration at port site wound.

Timeline

• Start date: 2022-03-01
• Primary completion: 2022-09-01
• Completion: 2022-09-01
• First posted: 2022-03-03
• Last updated: 2022-03-03